BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Chapter

Reset

Active filters

Product: Tolterodine

Presentation	Product	Chemical substance	Chapter	Items dispensed
Tolterodine 2mg tablets 0704020N0AAABAB	Tolterodine	Tolterodine	Obstetrics, Gynaecology and Urinary-Tract Disorders	107,736
Tolterodine 1mg tablets 0704020N0AAAAAA	Tolterodine	Tolterodine	Obstetrics, Gynaecology and Urinary-Tract Disorders	45,305
Tolterodine 4mg modified-release capsules 0704020N0AAACAC	Tolterodine	Tolterodine	Obstetrics, Gynaecology and Urinary-Tract Disorders	40,921
Tolterodine 2mg modified-release capsules 0704020N0AAAIAI	Tolterodine	Tolterodine	Obstetrics, Gynaecology and Urinary-Tract Disorders	9,241
Tolterodine 2mg/5ml oral suspension 0704020N0AAAJAJ	Tolterodine	Tolterodine	Obstetrics, Gynaecology and Urinary-Tract Disorders	182
Tolterodine 1mg/5ml oral liquid 0704020N0AAAHAH	Tolterodine	Tolterodine	Obstetrics, Gynaecology and Urinary-Tract Disorders	No data available
Tolterodine 2mg oral powder sachets 0704020N0AAAFAF	Tolterodine	Tolterodine	Obstetrics, Gynaecology and Urinary-Tract Disorders	No data available
Tolterodine 2mg/5ml oral solution 0704020N0AAAEAE	Tolterodine	Tolterodine	Obstetrics, Gynaecology and Urinary-Tract Disorders	No data available
Tolterodine 4mg/5ml oral liquid 0704020N0AAAGAG	Tolterodine	Tolterodine	Obstetrics, Gynaecology and Urinary-Tract Disorders	No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.